Hans Herfarth
UNC Chapel Hill
Appearances
DateMay 21, 2024SOCIETY: AGA This session is the second session of the ever-popular and clinically impactful clinical trials sessions in IBD. Insights into novel agents including obefazimod, VTX002. MH002, risankizumab, and mirikizumab will be presented…Moderators
Cleveland ClinicUNC Chapel Hill
DateMay 5, 2025This session will examine state of the art pivotal trials on efficacy of various biologic therapies for management of IBD…Moderators
University of California san franciscoUNC Chapel Hill
